Table 1.
Ki (nM) | |||||||||
Receptor/cell line | PGD2 | PGE2 | PGF2α | 9α,11β-PGF2α | PGJ2 | Δ12-PGJ2 | 15-deoxy-Δ12,14-PGJ2 | PGI2 | Reference |
hDP2/K562 | 61 ± 23 | 31,000 ± 11,000 | 2,000 ± 780 | - | 460 ± 160 | 7,100 ± 1,600 | 2,300 ± 400 | - | Hirai et al. 2001 |
hDP2/HEK293 | 2.4 ± 0.7 | 4,730 ± 64 | 395 ± 77 | 315 ± 92 | 6.6 ± 0.3 | 6.8 ± 0.35 | 3.2 ± 0.3 | - | Sawyer et al. 2002 |
mDP2/HEK293 | 32 ± 6 | - | - | - | - | - | - | - | Hata et al. 2005 |
mDP2/HEK293 | 38 ± 6 | 32,000 ± 400 | 600 ± 50 | - | 45.7 ± 0.2 | 410 ± 20 | 24 ± 4 | - | Hata et al. 2003 |
hDP2/K562 | 61 ± 23 | 3,100± 1100 | 2,000± 780 | - | 460 ± 160 | 7,100 ± 1,300 | 2,300 ± 400 | Hirai et al. 2001 | |
hDP1/K562 | 45 ± 17 | 2,300± 1100 | >30,000 | - | 64 ± 13 | 5,200 ± 1,700 | 30,000 | - | Hirai et al. 2001 |
hDP1/COS M-6a | 1.1 | 101 | 1,000 | - | - | - | - | - | Boie et al. 1995 |
hDP1/HEK293 | 0.6 ± 0.2 | 107 ± 42 | 367 ± 85 | - | 6.6± 0.3 | 100 ± 13 | 280 ± 30 | - | Wright et al. 1998 |
hDP1/HEK293 | 1.7 ± 0.3 | 307± 106 | 861 ± 139 | - | - | - | - | - | Sawyer et al. 2002 |
DP/human platelets | 81 ± 5 | >10,000 | 18,000 ± 6,460 | - | - | - | - | 3537 | Sharif et al. 2003 |
DP/human platelets | 80.3 ± 5.5 | 11,000 ± 2,190 | 32,000 ± 3,500 | - | - | - | - | - | Sharif et al. 2000a |
DP/human platelets | 80 ± 5 | 11,000 ± 2,100 | 18,000 ± 6,400 | - | - | - | - | - | Sharif et al. 2000b |
EC50 (nM) | |||||||||
Receptor/cell line | PGD2 | PGE2 | PGF2α | 9α,11β-PGF2α | PGJ2 | Δ12-PGJ2 | 15-deoxy-Δ12,14-PGJ2 | PGI2 | Reference |
hDP2/HEK293b | 1.6± 0.3 | - | 456 ± 169 | 856 ± 322 | 13.1 ± 5.36 | 10.8 ± 3.4 | 11.6 ± 6.3 | - | Sawyer et al. 2002 |
mDP2/HEK293 | 0.7 ± 0.3 | - | - | - | - | - | - | - | Hata et al. 2005 |
mDP2/HEK293 | 0.9 ± 0.2 | - | - | - | - | - | 0.8 ± 0.3 | - | Hata et al. 2003 |
hDP1/HEK293 | 1.38 ± 0.785 | 206 ± 156 | 1,090 ± 975 | - | - | - | - | - | Suganami et al. 2016 |
hDP1/HEK293a | 10 | 500 | 1000 | - | - | - | - | - | Boie et al. 1995 |
hDP1/HEK293 | 0.5 ± 0.1 | 84 ± 1 | 264 ± 22 | - | 1.2 ± 0.1 | 91 ± 18 | 321 ± 15 | - | Wright et al. 1998 |
bDP/EbTr | 74 | >1,000 | >10,000 | - | - | - | - | >10,000 | Sharif et al. 2003 |
hDP/human platelets | 98 ± 10 | >10,000 | >10,000 | - | - | - | - | - | Sharif et al. 2000b |
Abbreviations: h, human; m, mouse; b, bovine; HEK293, human embryonic kidney cells; K562, human erythroleukemia cells; COS M-6, Green monkey kidney cells; EbTr, bovine embryonic tracheal cells. The Ki values were determined from [3H]PGD2 displacement assays. The EC50 determined from intracellular changes in cAMP concentrations. a) Values determined from estimated IC50 taken from binding curves, utilizing the Cheng-Prusoff equation (Suganami et al. 2016); b) Ca2+ concentrations also measured.